News Focus
News Focus
icon url

abew4me

06/21/21 9:06 PM

#316462 RE: Investor2014 #316397

Was Orphazyme competing against any other drugs that were already approved for that rare disease?

Seems strange that the FDA would turn it down with stat sig results...unless it didn't show a better efficacy over the existing drugs?
icon url

powerwalker

06/21/21 10:41 PM

#316488 RE: Investor2014 #316397

Investor, the ORPH decision confirms for those who have researched this decision and Biogen adu* decision, how co**upt the fda (small letters used for effect).




ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
[/quote]